National Advisory Panel
Susan A. Ballagh, MD, has been
assistant professor in the Department of Obstetrics and Gynecology
at the Eastern Virginia Medical School in Norfolk and a member
of CONRAD (Contraceptive Research and Development) since 1997.
Prior to that, Dr. Ballagh was assistant professor in the
Department of Obstetrics and Gynecology at the Stanford University
Medical Center (1992-1997). During the same period, she was
chief of Women’s Health at the Department of Veterans
Affairs, Palo Alto.
Usually serving as principal investigator, Dr. Ballagh has
participated in many clinical trials. The areas of study have
been contraception, menopause, and women’s health conditions
including endometriosis, osteoporosis and incontinence. She
has addressed the same subjects in numerous lectures, articles,
abstracts and book chapters. Dr. Ballagh serves on the National
Medical Advisory Board for Planned Parenthood and is an ad
hoc reviewer for grant applications for the National Institutes
of Health. She also serves as an ad hoc reviewer for Contraception,
Fertility and Sterility, and the Journal of Adolescent Gynecology.
Dr. Ballagh received her medical degree from Drew/UCLA Medical
Education Program at the University of California at Los Angeles
in 1986. She completed a residency in obstetrics and gynecology
in 1990 and a fellowship in reproductive endocrinology and
contraception in 1992 at Los Angeles County/University of
Southern California Medical Center. She is board certified
in reproductive endocrinology and obstetrics and gynecology.
Prior to her medical training, Dr. Ballagh was a WIC nutritionist,
completing her didactic internship and master’s degree
in nutrition at the University of Wisconsin at Madison.
Dr. Ballagh is engaged in research for Barr Laboratories,
Berlex Laboratories, Conceptus, Inc., Eli Lilly, Pharmacia/Pfizer,
Galen/Warner-Chilcott, Organon, Watson Pharmaceuticals and
Wyeth Pharmaceuticals. She serves on the speakers’ bureaus
of AHRP, Berlex Laboratories, Cardinal Health, Inc., Council
on Hormone Education, Galen/Warner-Chilcott, Health Learning
Systems, Organon, Inc., Ortho Pharmaceutical Corporation and
Wyeth Pharmaceuticals. Dr. Ballagh is a consultant for Galen/Warner-Chilcott
and Gerson-Lehrman Group.
Paul Blumenthal, MD, MPH, has been associate
professor of Obstetrics and Gynecology at Johns Hopkins University,
Baltimore, Maryland, since 1995. During the same period, he
has served as director of the university’s Fellowship
Program in Family Planning Clinical Care and Research and
an associate in its Population Center. In 1999, he became
medical director of the Cervical Cancer Prevention Project,
a collaborative effort with the JHPIEGO Corporation ( A Johns
Hopkins Program for Training In Reproductive Health). He has
been a member of the Johns Hopkins University faculty since
Since 1988, he has been a consultant to several international
programs administered by JHPIEGO, International Projects Assistance
Services (IPAS), and Family Health International (FHI). Involving
numerous countries in Africa, the former Soviet Union, and
Southeast Asia, the consultations have concerned the introduction
of reproductive health technology and training and curriculum
development in obstetrics and gynecology.
From 1987 to 1988, he was co-director of the Uro-Gynecology
Program at Michael Reese Hospital and Medical Center in Chicago,
Illinois. From 1984 to 1988, he was assistant professor in
the Department of Obstetrics and Gynecology at the University
of Chicago Pritzker School of Medicine. From 1989 through
1990 he was a visiting lecturer at the University of Nairobi
and Kenyatta National Hospital in Nairobi Kenya.
Active in research, he is currently leading studies of oral,
barrier, and implant contraceptive methods and visual inspection
of the cervix in detecting and preventing cervical cancer.
He is also studying the use of mifepristone and misoprostol
in medical abortions and reproductive health training and
contraceptive and sterilization services in the developing
He was medical director of Planned Parenthood in Maryland
from 1994 to 2001 and has been a member of the National Medical
Committee of the Planned Parenthood Federation of America
since 1996. In 2000, he was special advisor to the World Health
Organization on the development of technical guidelines for
program managers in abortion care.
He received his medical degree from The University of Health
Sciences/ The Chicago Medical School in 1977 and completed
a residency in obstetrics and gynecology at the Michael Reese
Hospital and Medical Center in 1982. In 1984, he undertook
an additional residency in the Department of Preventive Medicine
and a fellowship in reproductive epidemiology at the University
of California at Los Angeles.
Dr. Blumenthal is engaged in research for Berlex, Barr and
the Gates Foundation. He is a consultant for USAID, WHO, JHPIEGO,
and IPAS and a member of the speakers’ bureau for Berlex
PonJola Coney, MD, is senior vice
president for Health Affairs and dean of the School of Medicine
at Meharry Medical College in July 2002. Dr. Coney earned
her medical degree at the University of Mississippi Medical
Center and completed a residency at the University of North
Carolina-Chapel Hill. She developed successful infertility
treatment programs during her tenure at the University of
Oklahoma, University of Nebraska and University of Arizona.
A leader in reproductive medicine, Dr. Coney’s research
interests have focused on menopausal health, contraception
and assisted reproduction. She came to Meharry from Southern
Illinois University School of Medicine, where she served since
1995 as professor and chair of the department of obstetrics
and gynecology. She has over 40 publications in medical literature.
A founding director of the Society for Executive Leadership
in Academic Medicine, Dr. Coney is active in numerous professional
organizations. Her appointment is historic for the Hedwig
van Amerigen Executive Leadership in Academic Medicine program
(ELAM), a national group formed to advance women in the ranks
of medicine. Her appointment at Meharry represented a significant
accomplishment for women in academic medicine when she became
the first of ELAM's inaugural class to ascend to the position
of dean of a medical school.
Dr. Coney is engaged in research for Wyeth.
Paula J. Adams Hillard, MD,
has taught at the University of Cincinnati College of Medicine
in Ohio since 1984, becoming professor of Obstetrics and Gynecology
in 1997 and professor of Pediatrics in 2000. From 1981 to
1984, she was assistant professor of Obstetrics and Gynecology
at the University of Virginia in Charlottesville. During the
same period, she was the university’s director of Ambulatory
Obstetrics and Gynecology.
Her research interests include ambulatory obstetrics and gynecology,
primary care gynecology and adolescent gynecology, including
contraceptive methods and compliance. In addition, she has
studied sexually transmitted diseases as well as sexual abuse
and domestic violence.
She is a member of the editorial boards of several journals,
including The Contraception Report, Contemporary Ob/Gyn,
and the Journal of Pediatric and Adolescent Gynecology.
She is also associate editor of Novak’s Gynecology
and the author of numerous book chapters on women’s
health. From 1982 to 1989, she wrote a monthly column for
Parent’s magazine on pregnancy and birth. In 1997,
she was named by Good Housekeeping magazine as one
of the “Best Doctors for Women.”
She has been an oral examiner for the American Board of Obstetrics
and Gynecology for 13 years. She is past Chair of the Committees
on Patient Education and Adolescent Health of the American
College of Obstetrics and Gynecology (ACOG), past vice-chair
of the Committee on Gynecologic Practice. She is currently
the Chair of the Guidelines for Women’s Health Committee.
She has also represented ACOG on the Committee on Adolescents
of the American Academy of Pediatrics.
In 1977, she obtained her medical degree from Stanford University
School of Medicine in Palo Alto, California, and completed
her residency in obstetrics and gynecology at the University
of North Carolina in Chapel Hill in 1981.
Dr. Hillard is engaged in research for Berlex and Wyeth Pharmaceuticals.
She is a consultant and advisory board member for Proctor
and Gamble. She is a member of the speakers' bureaus at Pharmacia-Upjohn,
3-M Pharmaceuticals, Pfizer, Organon, Ortho-McNeill, Barr
Labs and Wyeth Pharmaceuticals.
Catherine M. Lynch, MD, has been
associate professor of Obstetrics and Gynecology at the University
of South Florida in Tampa since 1994. During the same period,
she has also served as the university’s director of
the Division of General Obstetrics and Gynecology. In addition,
she is co-medical Director of the Women’s Cancer Screening
Center at the Tampa General Hospital.
Her research interests encompass general obstetrics and gynecology,
contraceptive and hormonal therapy, urogynecologic surgery
and urodynamics, and pelvic reconstruction.
She received her medical degree from the University of South
Florida College of Medicine in 1990 and completed her residency
at the same college in 1994.
Dr. Lynch is engaged in research for Wyeth. She is a member
of the speakers' bureaus at Wyeth, Pfizer and Berlex.
Alfred N. Poindexter, III, MD,
received his medical degree in 1968 from Meharry Medical College
in Nashville, Tennessee and completed a residency in obstetrics
and gynecology at the University of Missouri, Kansas City
General Hospital in 1972. In addition, he completed a post-doctoral
fellowship in reproductive endocrinology at the Baylor College
of Medicine in 1976.
Dr. Poindexter has been a faculty member at Baylor since 1975.
He is director of the Division of Contraceptive Research and
Development, Director of Gynecological Services in the Baylor
Population Program, and Director of the Reproductive Endocrinology
Service at the University of Houston. He is also chairman
of Baylor's Affirmative Action Committee. Dr. Poindexter also
holds clinical appointments at four hospitals in Houston.
Dr. Poindexter has been a board examiner for the American
Board of Obstetrics and Gynecology since 1988 and is currently
an ad hoc member of the editorial boards of the New England
Journal of Medicine, American Journal of Obstetrics
and Gynecology, Fertility and Sterility, and
Obstetrics and Gynecology. He has been a member of
the Board of Directors and was secretary of the Planned Parenthood
Federation of America.
Dr. Poindexter has participated in numerous studies concerning
the efficacy of contraceptive drugs, devices, and programs,
often serving as principal investigator. His current research
focuses on tubal sterilization and a new spermicidal agent.
Past research has covered oral and vaginal contraceptives.
Dr. Poindexter is engaged in research for Columbia Labs, Organon,
Ortho-McNeil and Wyeth Pharmaceuticals. He is a consultant
for Wyeth Pharmaceuticals, Zonagena and Organon and a member
of the speakers' bureaus for Johnson & Johnson, Ortho-McNeil
Frank Z. Stanczyk, PhD, is
professor of Research at the University of Southern California
School of Medicine in Los Angeles, holding that position in
the Department of Obstetrics and Gynecology since 1994 and
in the Department of Preventive Medicine since 1999. He has
been a member of the medical school faculty since 1986.
From 1983 to 1986, he was associate scientist at the Oregon
Regional Primate Research Center in Beaverton and associate
professor in the Department of Obstetrics and Gynecology at
the Oregon Health Sciences University in Portland. He held
assistant professorships in obstetrics and gynecology at the
same university from 1980 to 1984 and at the University of
Southern California from 1975 to 1980. The latter university
was also the site of a postdoctoral research fellowship in
obstetrics and gynecology from 1972 to 1974.
His research interests include the pharmacokinetics and metabolism
of estrogens, progestins and androgens in postmenopausal women,
the effect of contraceptive steroids on androgens, and the
role of steroid hormones in the etiology of Alzheimer’s
disease, lupus erythematosis, multiple sclerosis, and prostate,
ovarian, and breast cancer. Current projects include the effect
of exogenous DHEA on serum levels of DHEA, its major metabolites,
and cardiovascular and skeletal markers in postmenopausal
women, and the effect of steroid hormones on cognitive function
and mood in women during the menstrual cycle, pregnancy, and
postpartum, as well as in men and women with Alzheimer’s
He has authored or co-authored almost 200 articles and 200
abstracts (published or in preparation) on progestins, estrogens,
and other steroid hormones. In addition, he has been associate
editor of Contraception since 1991, and a member
of the editorial boards of Steroids and the Journal
of the Society of Gynecologic Investigation since 1995.
He received his doctoral degree in experimental medicine from
McGill University in Montreal, Quebec in 1972.
Dr. Stanczyk has no relationships to disclose.
Robert A. Wild, MD, MPH, is professor
and chief of Reproductive Endocrinology and Infertility in
the Department of Obstetrics and Gynecology, and adjunct professor
of Medicine (Cardiology) and Biostatistics and Epidemiology
at the University of Oklahoma City Health Sciences Center
in Oklahoma City. He is an experienced clinician and investigator
with a focus on primary prevention strategies for women through
a combination of obstetrics and gynecology, preventive cardiology,
and public health practices.
Dr. Wild is a graduate of the University of Missouri School
of Medicine. He completed his residency in obstetrics and
gynecology at the Boston Hospital for Women, Harvard Medical
School. In 1998, he received a Master's of Public Health degree
in clinical epidemiology and biostatistics from the University
of Oklahoma Health Sciences Center. He is a diplomat of the
National Board of Medical Examiners and of the American Board
of Obstetrics and Gynecology (reproductive endocrinology subspecialty).
He is an examiner for the American Board of Obstetrics and
Gynecology (general and reproductive endocrine).
Dr. Wild is past President of Preventive Cardiology, the Society
of Reproductive Endocrinologists, and the Oklahoma City Obstetrical
and Gynecological Society. He is the only gynecologist to
have received a Preventive Cardiology Award from the National
Heart, Lung, and Blood Institute. He is on the advisory board
for the Office of Research on Women's Health (ORWH) at the
National Institutes of Health.
Dr. Wild's research interests include primary prevention strategies
for women, with a focus on the heart, reproductive endocrinology
(polycystic ovary syndrome and endometriosis), sex steroids,
and cardiovascular diseases.
Dr. Wild has no relationships to disclose.
Susan Wysocki, RNC, NP, is the President and CEO
of the National Association of Nurse Practitioners in Women's
Health (NPWH). She is a woman's health nurse practitioner
certified by the National Certification Corporation (NCC)
and is a nationally recognized speaker and opinion leader
in the field of women's health.
Ms. Wysocki is the editor of Clinical Challenges in Women's
Health: A Handbook for Nurse Practitioners. She is the
Editor of Women's Health Care: A Practical Journal
for Nurse Practitioners and Conversations in Counseling.
Further, she is a contributing editor and Washington, DC bureau
chief for Nurse Practitioner World News. Ms. Wysocki
also serves on the editorial boards of the American Journal
for Nurse Practitioners, Dialogues in Contraception,
and the Contraceptive Technology Update. She has
authored numerous articles in nursing publications.
In 1999, Ms. Wysocki was selected by a national panel of nurse
practitioners convened by the Nurse Practitioner Journal
for a Lifetime Achievement Award. In 2000, she was chosen
as a charter Fellow of the American Academy of Nurse Practitioners.
She has served as the Chair of the National Alliance of Nurse
Practitioners and was the founding president of the American
College of Nurse Practitioners.
Ms. Wysocki is a graduate of Boston College School of Nursing
and attained her certificate as a nurse practitioner through
the New Jersey College of Medicine and Dentistry and the Planned
Parenthood Federation of America.
Ms. Wysocki is on the advisory boards at Ortho-McNeil, Berlex,
Pfizer (Parke-Davis), Wyeth, 3M Corporation, Pharmacia, Solvay,
and Novavax. She serves on the speakers' bureaus for Ortho-McNeil,
Wyeth, Berlex, Organon, Pharmacia, and Pfizer (Parke-Davis).